Programmatic Cost-Effectiveness of a Second-Time Visit to Detect New Tuberculosis and Diabetes Mellitus in TB Contact Tracing in Myanmar

Background: Integration of diabetes mellitus screening in home visits for contact tracing for tuberculosis could identify hidden patients with either tuberculosis or diabetes mellitus. However, poor compliance to the first home screening has been reported. A second time visit not only increases screening compliance but also the cost. This study aimed to determine if an additional second time visit was cost effective based on the health system perspective of the tuberculosis contact tracing program in Myanmar. Methods: This cross-sectional study was based on usual contact tracing activity in the Yangon Region, Myanmar, from April to December 2018 with integration of diabetes mellitus screening and an additional home visit to take blood glucose tests along with repeated health education and counseling to stress the need for a chest X-ray. New tuberculosis and diabetes mellitus cases detected were the main outcome variables. Programmatic operational costs were calculated based on a standardized framework for cost evaluation on tuberculosis screening. The effectiveness of an additional home visit was estimated using disability-adjusted life years averted. The willingness to pay threshold was taken as 1250.00 US dollars gross domestic product per capita of the country. Results: Single and additional home visits could lead to 42.5% and 65.0% full compliance and 27.2 and 9.3 additional years of disability-adjusted life years averted, respectively. The respective base costs and additional costs were 3280.95 US dollars and 1989.02 US dollars. The programmatic costs for an extra unit of disability-adjusted life years averted was 213.87 US dollars, which was lower than the willingness to pay threshold. Conclusions: From the programmatic perspective, conducting the second time visit for tuberculosis contact tracing integrated with diabetes mellitus screening was found to be cost effective.

[1]  E. Huang,et al.  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. , 2021, Diabetes care.

[2]  J. Creswell,et al.  Cost-effectiveness of household contact investigation for detection of tuberculosis in Pakistan , 2021, BMJ Open.

[3]  S. Vollmer,et al.  Estimated effect of increased diagnosis, treatment, and control of diabetes and its associated cardiovascular risk factors among low-income and middle-income countries: a microsimulation model , 2021, The Lancet. Global health.

[4]  E. M. Woldesemayat.  Cost-Effectiveness of Follow-Up of Chronic Coughers in Detecting Smear-Positive Tuberculosis in South Ethiopia , 2021, ClinicoEconomics and outcomes research : CEOR.

[5]  M. Naghavi,et al.  The burden of diabetes and hyperglycemia in Brazil: a global burden of disease study 2017 , 2020, Population Health Metrics.

[6]  Laigden Dzed,et al.  Diabetes Case Burden at Central Regional Referral Hospital, Gelephu, Bhutan; A Retrospective Study , 2020, International Healthcare Research Journal.

[7]  J. Tripathy,et al.  Experiences from the pilot implementation of the Package of Essential Non-communicable Disease Interventions (PEN) in Myanmar, 2017-18: A mixed methods study , 2020, PloS one.

[8]  Z. Qin,et al.  Standardized framework for evaluating costs of active case-finding programs: An analysis of two programs in Cambodia and Tajikistan , 2020, PloS one.

[9]  J. Creswell,et al.  The cost-effectiveness of incentive-based active case finding for tuberculosis (TB) control in the private sector Karachi, Pakistan , 2019, BMC Health Services Research.

[10]  N. Kigozi,et al.  Yield of systematic household contact investigation for tuberculosis in a high-burden metropolitan district of South Africa , 2019, BMC Public Health.

[11]  N. Kak,et al.  Bidirectional Screening of Diabetes Mellitus and Tuberculosis in Cambodia , 2019, Journal of Tropical Diseases & Public Health.

[12]  A. Riewpaiboon,et al.  Unit cost analysis of medical services at different levels of health facilities of a township in Myanmar , 2019, Pharmaceutical Sciences Asia.

[13]  K. K. K. Htet,et al.  Improving detection of tuberculosis among household contacts of index tuberculosis patients by an integrated approach in Myanmar: a cross-sectional study , 2018, BMC Infectious Diseases.

[14]  Mike Paulden,et al.  Probabilistic Sensitivity Analysis in Cost-Effectiveness Models: Determining Model Convergence in Cohort Models , 2018, PharmacoEconomics.

[15]  M. Engelbrecht,et al.  Household contact non-attendance of clinical evaluation for tuberculosis: a pilot study in a high burden district in South Africa , 2018, BMC Infectious Diseases.

[16]  A. Htet,et al.  Urban–rural differences in the prevalence of diabetes mellitus among 25–74 year-old adults of the Yangon Region, Myanmar: two cross-sectional studies , 2018, BMJ Open.

[17]  D. Dowdy,et al.  Drop-out from the tuberculosis contact investigation cascade in a routine public health setting in urban Uganda: A prospective, multi-center study , 2017, PloS one.

[18]  J. Kaufman,et al.  Cost-effectiveness of active case-finding of household contacts of pulmonary tuberculosis patients in a low HIV, tuberculosis-endemic urban area of Lima, Peru , 2017, Epidemiology and Infection.

[19]  K. K. K. Htet,et al.  Cost-effectiveness of a new strategy to detect pulmonary tuberculosis in household contacts in Myanmar. , 2017, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[20]  B. Duncan,et al.  Cost-effectiveness of a national population-based screening program for type 2 diabetes: the Brazil experience , 2015, Diabetology & Metabolic Syndrome.

[21]  D. Wangchuk,et al.  Is diabetes and hypertension screening worthwhile in resource-limited settings? An economic evaluation based on a pilot of a Package of Essential Non-communicable disease interventions in Bhutan. , 2015, Health policy and planning.

[22]  G. Gebregergs,et al.  Household Contact Screening Adherence among Tuberculosis Patients in Northern Ethiopia , 2015, PloS one.

[23]  J. Orozco,et al.  Cost-effectiveness analysis of the available pneumococcal conjugated vaccines for children under five years in Colombia , 2015, Cost Effectiveness and Resource Allocation.

[24]  Anthony D Harries,et al.  Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice. , 2014, The lancet. Diabetes & endocrinology.

[25]  Y. Lubell,et al.  Cost-Effectiveness of a Tuberculosis Active Case Finding Program Targeting Household and Neighborhood Contacts in Cambodia , 2014, The American journal of tropical medicine and hygiene.

[26]  G. Bloomfield,et al.  Screening for diabetes and hypertension in a rural low income setting in western Kenya utilizing home-based and community-based strategies , 2013, Globalization and Health.

[27]  A. Harries,et al.  Screening of patients with tuberculosis for diabetes mellitus in China , 2012, Tropical medicine & international health : TM & IH.

[28]  Eberechukwu Onukwugha,et al.  Sensitivity Analysis in Cost-Effectiveness Studies , 2011, PharmacoEconomics.

[29]  J. Bryant,et al.  The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation. , 2011, Health technology assessment.

[30]  Anna Vassall,et al.  Rapid Diagnosis of Tuberculosis with the Xpert MTB/RIF Assay in High Burden Countries: A Cost-Effectiveness Analysis , 2011, PLoS medicine.

[31]  Sarah Wordsworth,et al.  Applied Methods of Cost-Effectiveness Analysis in Healthcare , 2010 .

[32]  P. Hopewell,et al.  Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. , 2008, The Lancet. Infectious diseases.

[33]  C. Pipper,et al.  [''R"--project for statistical computing]. , 2008, Ugeskrift for laeger.

[34]  G. Roglić,et al.  Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence , 2007, BMC public health.

[35]  J. Kaewkungwal,et al.  Factors associated with the household contact screening adherence of tuberculosis patients. , 2005, The Southeast Asian journal of tropical medicine and public health.

[36]  Christos E. Papadopoulos,et al.  Uncertainty estimation and Monte Carlo simulation method , 2001 .

[37]  C. Dolea,et al.  World Health Organization , 1949, International Organization.